Company Filing History:
10 out of 1,345 
1 out of 49 
1 out of 413 
Years Active: 2009-2023
Title: Innovative Contributions of Ivan Borisovich Lobov in Biotechnology
Introduction: Ivan Borisovich Lobov is a prominent inventor based in New York, NY, known for his significant contributions to the field of biotechnology. With a remarkable portfolio of 12 patents, Lobov has played a pivotal role in advancing therapeutic treatments aimed at various diseases. His innovative methods primarily focus on the apelin receptor (APLNR) and its implications in the medical field.
Latest Patents: Among Ivan Lobov's latest patents is the groundbreaking invention titled "Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody." This invention offers novel APLNR modulators that can bind to the apelin receptor, providing methods for treating diseases associated with APLNR signaling, including cardiovascular, metabolic, and fibrotic diseases. Additionally, his patent "Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors" presents therapeutic approaches for eye diseases through the administration of combinations of APLNR antagonists and VEGF inhibitors.
Career Highlights: Throughout his career, Lobov has been associated with reputable companies such as Regeneron Pharmaceuticals, Inc., where he made significant strides in biotechnology research. His work has garnered recognition and respect in the scientific community, primarily due to his focus on treatments involving innovative protein-based therapies.
Collaborations: Ivan Lobov has had the opportunity to collaborate with esteemed colleagues such as Panayiotis Stevis and Andrew J. Murphy. Their combined expertise in biotechnology has undoubtedly contributed to the development of impactful inventions and advancements in therapeutic strategies.
Conclusion: Ivan Borisovich Lobov's contributions to the field of biotechnology are marked by his innovative patents and collaborations that aim to address critical health challenges. As he continues to develop and refine therapeutic methodologies, his work remains essential in the fight against various diseases and disorders, showcasing the potential of targeted treatment and biopharmaceutical advancements.